The White House’s call Thursday (April 21) for federal agencies to increase access to substance use treatments as part of a broader strategy to address the opioid overdose epidemic makes no mention of allowing drugs to be prescribed via telehealth. The administration faces pressure from key lawmakers and stakeholders to continue COVID-19 public health emergency flexibilities that have allowed controlled substances, like the substance use disorder treatment buprenorphine, to be available through telehealth. The Senate Finance Committee pressed HHS Secretary...